Daniel Barber's Insider Trades & SAST Disclosures
Daniel Barber's most recent trade in Aquestive Therapeutics Inc was a trade of 408,000 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on March 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Daniel Barber.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 408,000 | 408,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 272,000 | 1,098,478 (3%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 53,998 | 1,015,173 (3%) | 0% | 2.7 | 143,095 | Common Stock |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 29,307 | 1,069,171 (3%) | 0% | 2.7 | 77,664 | Common Stock |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 09 Mar 2024 | 56,824 | 826,478 (2%) | 0% | 4.9 | 277,301 | Common Stock |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 09 Mar 2024 | 37,938 | 845,364 (2%) | 0% | 4.9 | 185,137 | Common Stock |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 363,900 | 363,900 | - | - | Non-Qualified Stock Option (right to buy) | |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 242,600 | 883,302 (2%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2023 | 223,500 | 223,500 | - | - | Performance Stock Units | |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 223,500 | 223,500 | - | - | Performance Stock Units | |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 447,000 | 640,702 (1%) | 1% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 100,000 | 100,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Aquestive Therapeutics Inc | Daniel Barber | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Jun 2022 | 91,743 | 91,743 | - | - | Warrant (Right to Buy) | |
| Aquestive Therapeutics Inc | Daniel Barber | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.96 per share. | 08 Jun 2022 | 91,743 | 193,702 (0%) | 0% | 1.0 | 88,073 | Common Stock |
| Aquestive Therapeutics Inc | Daniel Barber | SVP-Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 225,000 | 225,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Aquestive Therapeutics Inc | Daniel Barber | SVP-Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 100,000 | 100,000 | - | - | Non-Qualified Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges